Get a free instant audit of your site, real findings in 15 seconds. Try it →
Industries Healthcare Industrial B2B Consumer Property & Development Professional & Trade Services Retail & Hardware Automotive (4x4) Fashion & Beauty Instant Audit Services Work Platform Why 121 Pricing Free Audit Founder Call Resources News About 1300 121 979 Book a Discovery
Book a Discovery
📞 1300 121 979 Book a Discovery
← News Healthcare · Diagnostics · June 2026

The diagnostics + pathology marketing playbook.

By Adam Ducquet · 8 June 2026 · 2 min read

Diagnostics + pathology businesses have three distinct buyer audiences (GP referrers, hospital procurement, B2C patients) and a long-tail SEO surface that compounds for niche-test queries (NIPT, PGx, hereditary cancer panels). Genomic Diagnostics is the worked example.

AD
Adam Ducquet
Managing Director - Head of Strategy · 121 Group · Senior strategist

Three buyer audiences, three programmes

Buyer 01, GPs and referring specialists

CME-style educational content on niche tests, pathology-form-portal UX, GP-portal feature awareness, GP CPD events, RACGP-aligned content. Email cadence to referring practices, not patients. The relationship-led, slow-build, compounding referral economy.

Buyer 02, Hospital + PE procurement

For pathology contracts with hospital networks and integrated healthcare groups, the buyer is procurement. Capability statements, service-coverage maps, accreditation documentation, same B2B procurement disciplines as occupational health. Tier-1 panel-pursuit-grade evidence depth.

Buyer 03, Direct-to-consumer patients

For B2C genetic testing, hereditary cancer panels, patient-funded screening, the buyer is the patient. Meta + Google for patient-direct acquisition, patient-education funnel, AHPRA-reviewed claims, GP-referral integration where required.

The long-tail SEO surface

"NIPT cost Australia bulk billing", "PGx Medicare item number", "hereditary cancer panel BRCA testing AU", "pharmacogenomic test medication review". The niche-test long-tail is a major referrer-acquisition + B2C-acquisition channel. Genomic Diagnostics ranks for hundreds of these queries because the content has been built specifically for them.

Clinical content authority discipline

For high-stakes diagnostic categories, content has to be clinically authoritative. We run pathologist co-author models (named pathologist as content author with bio + credentials), citation-grade evidence requirements (peer-reviewed sources only), and AHPRA review on every public-facing piece. Brand-trained Imagen for supporting visuals, hand-finished diagrams for clinical figures.

Read more:

↑ Back to top

Running a diagnostics + pathology business?

Forty-five-minute call. We'll review your three-audience approach, your niche-test SEO, and your AHPRA-aligned content.

Book a Discovery
Adam Ducquet
Adam Ducquet
Founder and Managing Director, 121 Group. Twenty years building measurable growth programmes for Australian brands, and the senior strategist on every account.
About Adam · LinkedIn · Published 08/06/2026